Stay updated on REGN3500 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedPage revision metadata updated: added Revision v3.3.4 and removed Revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedA new 'Locations' section has been added listing study sites across multiple US states (Arizona, California, Florida, Georgia, Maryland, Michigan, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Texas, and Virginia).SummaryDifference0.9%

- Check54 days agoChange DetectedRevision label in the page footer changed from v3.2.0 to v3.3.2, indicating a version update with no apparent changes to study data or criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedThe government funding/operating status notice was removed from the page footer. This is a minor footer content change and does not affect study details or user actions.SummaryDifference0.2%

- Check82 days agoChange DetectedNo significant changes to the core content of the Study Details page (e.g., study title, objectives, eligibility, endpoints, or locations) are visible between the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check104 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference2%

Stay in the know with updates to REGN3500 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 in Atopic Dermatitis Clinical Trial page.